Corrigendum to “Does ivermectin have a place in the treatment of mild Covid-19?” [New Microbes New Infect 46 (C) (2022 Mar) 100985] (New Microbes and New Infections (2022) 46, (S2052297522000373), (10.1016/j.nmni.2022.100985))

Research output: Contribution to journalComment/debate

Abstract

The author regrets having incorrectly used in the Forest-Plot figure, under the column of “Total” the numbers which were the “non-events” numbers instead of the Total numbers. This is corrected now and has changed the Risk Ratio (95% CI) being now 0.77 (0.60-0.98) and P = 0.04. These numbers were corrected in the figure and also in the last 2 lines of Table 1. The corrected Figure and |Table are enclosed. These changes did not affect any of the conclusions of the manuscript. The authors would like to apologise for any inconvenience caused. Fig. 1. Effect of ivermectin on prevention of hospitalization including studies with low concerns for bias. (Ref [3,7–9]).[Formula

Original languageEnglish
Article number101000
JournalNew Microbes and New Infections
Volume48
DOIs
StatePublished - Jul 2022

Fingerprint

Dive into the research topics of 'Corrigendum to “Does ivermectin have a place in the treatment of mild Covid-19?” [New Microbes New Infect 46 (C) (2022 Mar) 100985] (New Microbes and New Infections (2022) 46, (S2052297522000373), (10.1016/j.nmni.2022.100985))'. Together they form a unique fingerprint.

Cite this